CytoDyn’s Promotion Of Investigational Drug Leronlimab Once Again Rebuked By US FDA

 
• By Brenda Sandburg
  
Monoclonal antibody
CytoDyn video promotion for its investigational COVID-19 treatment draws FDA warning letter • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Archive

More from Pink Sheet